Back

dr. K.P.M. (Karijn) Suijkerbuijk

dr. K.P.M. (Karijn) Suijkerbuijk

Associate Professor
dr. K.P.M. (Karijn) Suijkerbuijk
  • Department of Medical Oncology

Biography

Biography

Karijn Suijkerbuijk is a translational medical oncologist with special interest in melanoma and immunotherapy. During her PhD, she performed research on tumor epigenetics in breast cancer in the lab of Professor Saraswati Sukumar at the Sidney Kimmel Cancer Center at Johns Hopkins University. Dr. Suijkerbuijk currently participates in multiple phase II and III clinical trials on immune checkpoint inhibitors. She published papers in Oncogene, Annals of Oncology and JNCI, received research grants from KWF and NWO and was awarded an ASCO Merit Award. Her current research focuses on clinical and immunological parameters assoaciated with immune related adverse events during checkpoint inhibition and clinicopathological factors associated with checkpoint inhibitor response.

Fellowship and Awards

2007  Research year for residents (UU2007-3977) KWF
2008  Translational grant KWF (UU-2008-4217
2008  AGIKO stipend, ZonMW
2008  ASCO Merit Award

2018 ZonMW goed gebruik geneesmiddelen

Research Output (75)

TNF inhibition for immune checkpoint inhibitor-induced irAEs:the jury is still out

Suijkerbuijk Karijn P M, Verheijden Rik J 8 jun 2021, In: Nature Reviews. Rheumatology. 17 , p. 505

Toxicity, response and survival in older patients with metastatic melanoma treated with checkpoint inhibitors<sup>†</sup>

de Glas Nienke A., Bastiaannet Esther, van den Bos Frederiek, Mooijaart Simon P., van der Veldt Astrid A.M., Suijkerbuijk Karlijn P.M., Aarts Maureen J.B., van den Berkmortel Franchette W.P.J., Blank Christian U., Boers-Sonderen Marye J., van den Eertwegh Alfonsus J.M., de Groot Jan Willem B., Haanen John B.A.G., Hospers Geke A.P., Jalving Hilde, Piersma Djura, van Rijn Rozemarijn S., Ten Tije Albert J., Vreugdenhil Gerard, Wouters Michel W.J.M., Portielje Johanneke E.A., Kapiteijn Ellen W. 1 jun 2021, In: Cancers. 13

The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition:A multicentre retrospective analysis

Versluis Judith M, Hendriks Anne M, Weppler Alison M, Brown Lauren J, de Joode Karlijn, Suijkerbuijk Karijn P M, Zimmer Lisa, Kapiteijn Ellen W, Allayous Clara, Johnson Douglas B, Hepner Adriana, Mangana Joanna, Bhave Prachi, Jansen Yanina J L, Trojaniello Claudia, Atkinson Victoria, Storey Lucy, Lorigan Paul, Ascierto Paolo A, Neyns Bart, Haydon Andrew, Menzies Alexander M, Long Georgina V, Lebbe Celeste, van der Veldt Astrid A M, Carlino Matteo S, Sandhu Shahneen, van Tinteren Harm, de Vries Elisabeth G E, Blank Christian U, Jalving Mathilde 7 mei 2021, In: European Journal of Cancer. 151 , p. 72-83 12 p.

Checkpoint inhibition:protecting against or predisposing for second primary tumors?

Suijkerbuijk K P M, May A M, van Eijs M J M 29 mrt 2021, In: Annals of oncology : official journal of the European Society for Medical Oncology. 32 , p. 935-935 1 p.

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma:the multicentre prospective Safe Stop trial

Mulder E E A P, de Joode K, Litière S, Ten Tije A J, Suijkerbuijk K P M, Boers-Sonderen M J, Hospers G A P, de Groot J W B, van den Eertwegh A J M, Aarts M J B, Piersma D, van Rijn R S, Kapiteijn E, Vreugdenhil G, van den Berkmortel F W P J, Hoop E Oomen-de, Franken M G, Ryll B, Rutkowski P, Sleijfer S, Haanen J B A G, van der Veldt A A M 25 mrt 2021, In: BMC Cancer. 21

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease:A Cohort Study

van der Kooij Monique K, Suijkerbuijk Karijn P M, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Boers-Sonderen Marye J, van Breeschoten Jesper, van den Eertwegh Alfonsus J M, B de Groot Jan Willem, Haanen John B A G, Hospers Geke A P, Piersma Djura, van Rijn Rozemarijn S, Ten Tije Albert J, van der Veldt Astrid A M, Vreugdenhil Gerard, van Zeijl Michiel C T, Wouters Michel W J M, Dekkers Olaf M, Kapiteijn Ellen 16 feb 2021, In: Annals of Internal Medicine. 174 , p. 641-648 8 p.

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events-A Comprehensive Review

Hommes Josefien W, Verheijden Rik J, Suijkerbuijk Karijn P M, Hamann Dörte 11 feb 2021, In: Frontiers in oncology. 10

Postapproval trials versus patient registries:comparability of advanced melanoma patients with brain metastases

Ismail Rawa K, Sikkes Nienke O, Wouters Michel W J M, Hilarius Doranne L, Pasmooij Anna M G, van den Eertwegh Alfonsus J M, Aarts Maureen J B, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, de Groot Jan Willem B, Haanen John B A G, Hospers Geke A P, Kapiteijn Ellen, Piersma Djura, van Rijn Roos S, Suijkerbuijk Karijn P M, Ten Tije Bert-Jan, van der Veldt Astrid A M, Vreugdenhil Art, van Dartel Maaike, de Boer Anthonius 1 feb 2021, In: Melanoma Research. 31 , p. 58-66 9 p.

Survival outcomes of patients with advanced melanoma from 2013 to 2017:Results of a nationwide population-based registry

van Zeijl M. C.T., de Wreede L. C., van den Eertwegh A. J.M., Wouters M. W.J.M., Jochems A., Schouwenburg M. G., Aarts M. J.B., van Akkooi A. C.J., van den Berkmortel F. W.P.J., de Groot J. W.B., Hospers G. A.P., Kapiteijn E., Piersma D., van Rijn R. S., Suijkerbuijk K. P.M., ten Tije A. J., van der Veldt A. A.M., Vreugdenhil G., van der Hoeven J. J.M., Haanen J. B.A.G. feb 2021, In: European Journal of Cancer. 144 , p. 242-251 10 p.

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Rogiers Aljosja, Pires da Silva Ines, Tentori Chiara, Tondini Carlo Alberto, Grimes Joseph M, Trager Megan H, Nahm Sharon, Zubiri Leyre, Manos Michael, Bowling Peter, Elkrief Arielle, Papneja Neha, Vitale Maria Grazia, Rose April A N, Borgers Jessica S W, Roy Severine, Mangana Joanna, Pimentel Muniz Thiago, Cooksley Tim, Lupu Jeremy, Vaisman Alon, Saibil Samuel D, Butler Marcus O, Menzies Alexander M, Carlino Matteo S, Erdmann Michael, Berking Carola, Zimmer Lisa, Schadendorf Dirk, Pala Laura, Queirolo Paola, Posch Christian, Hauschild Axel, Dummer Reinhard, Haanen John, Blank Christian U, Robert Caroline, Sullivan Ryan J, Ascierto Paolo Antonio, Miller Wilson H, Stephen Hodi F, Suijkerbuijk Karijn P M, Reynolds Kerry L, Rahma Osama E, Lorigan Paul C, Carvajal Richard D, Lo Serigne, Mandala Mario, Long Georgina V 19 jan 2021, In: Journal for ImmunoTherapy of Cancer. 9

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet